wikimedia.org
SIB experts and resources in the fight against COVID-19 (evolving list):

• UniProtKB/Swiss-Prot: Knowledge of SARS-CoV-2 protein sequences and how they function
• ViralZone: Biological insights, including a detailed comparison with the SARS virus’ genome as well as cross-links to complementary resources. View Webinar of 14 April 2020
• SIB COVID-19 Integrated Knowledgebase: SPARQL endpoint providing access to integrated data from various sources (incl. SIB resources) relevant for research on SARS-CoV-2
• SWISS-MODEL: Three-dimensional homology models and links to experimental structures in PDB for SARS-CoV-2 proteins (updated weekly)
• SwissDrugDesign: A large collection of web-based tools covering all aspects of computer-aided drug design (CADD), allowing to design and model compounds tackling COVID-19
• V-pipe: Detection of within-host genetic variation of SARS-CoV-2 from viral NGS data
• PROSITE: Profiles and patterns for detection and annotation of SARS-CoV-2 proteins and homologs
• HAMAP: Family profiles and annotation rules for the detection and annotation of betacoronaviruses
• Cellosaurus: Frequently updated information page on the cell lines useful for the study of SARS-CoV-2
• neXtProt: Information and SPARQL queries about human proteins that bind SARS-CoV-2
• GlyConnect: Glycosylation information of COVID-19 spike protein produced from recombinant protein (HEK293 and BTI-Tn-5B1-4). View Webinar of 30 April 2020
• Nextstrain: Real-time tracking of the coronavirus genome evolution and regular reports
• COVID-19 Scenarios: Public health planning tool for COVID-19 outbreaks in communities across the world
• BEAST2 - COVID-19 Monitoring: Quantifying epidemiological dynamics in real time based on viral genomes and confirmed case data
• Computational Linguistics for COVID-19: Central hub in computational linguistics for COVID-19, including automated annotation of the scientific literature, and social media mining
• ABCD database: Sequences of antibodies binding to SARS-CoV-2 and host proteins, provided by: the Geneva Antibody Facility (UNIGE) with the support of the Swiss-Prot Group.